T he innate immune system is of crucial importance for the initiation of an efficient immune response against invading pathogens. To start an appropriate inflammatory response leading to the elimination of microorganisms, pathogens have to be distinguished from self. In recent years, a novel family of receptors has been identified as the key receptors recognizing pathogens: TLRs (for review, see Refs. 1 and 2).
TLRs are pattern recognition receptors that can sense conserved microbial patterns that are shared by groups of pathogens. TLR4, the receptor for LPS, is important for the recognition of Gramnegative bacteria, whereas cell wall components of Gram-positive bacteria (such as lipoteichoic acid and lipoproteins) are primarily recognized by TLR2. After recognition of the bacterial pathogenassociated molecular pattern, distinctive intracellular pathways are activated, which include several different adaptor molecules, such as MyD88, Mal (MyD88 adaptor-like, also known as TIRAP) (3, 4) , Toll/IL-1R domain-containing adaptor-inducing IFN-␤ (TRIF; 3 also known as TICAM-1) (5, 6) and TRIF adaptor-related adaptor molecule (TRAM, also known as TICAM-2) (7-9). TLR4 uses two different pathways. Until recently, it was believed that TLR4 only signals via the adaptor proteins MyD88 and Mal/TI-RAP, leading directly to NF-B activation (MyD88-dependent pathway). Recently, a second, MyD88-independent, signaling route for TLR4 was discovered involving the adaptor proteins TRIF and TRAM. This MyD88-independent pathway initiates the type 1 IFN response as well as late NF-B activation (10 -13) .
Nontypeable Haemophilus influenzae (NTHi) is a Gram-negative bacterium that is a commensal organism in the human respiratory tract and an important cause of localized infections such as middle ear infection, sinusitis, and conjunctivitis. Furthermore, this bacterium is a common cause of exacerbations in asthma or chronic obstructive pulmonary disease, and NTHi has been implicated as a frequent cause of community-acquired pneumonia (14 -17) . NTHi abundantly expresses lipooligosaccharides (LOS) as well as LPS on the bacterial cell wall. Like LPS, LOS contains a lipid A portion, and this is the portion recognized by TLR4. In line, Wang et al. (18) recently reported that C3H/HeJ mice, which have a mutated nonfunctional TLR4, are less able to mount an inflammatory response to an encapsulated type b H. influenzae in their lungs accompanied by impaired bacterial clearance. Furthermore, recent research demonstrated that capsule porins and bacterial lipoproteins from H. influenzae type B signal via TLR2 (19) . In contrast to other H. influenzae isolates, NTHi lacks a polysaccharide capsule (nontypeable). Nevertheless, NTHi has several TLR2 ligands on its surface, including the bacterial lipoproteins protein D, P2, or P6, a 16-kDa lipoprotein highly conserved in the outer membrane of all NTHi strains (20) .
In the present study we sought to determine the contributions of CD14, TLR2, and TLR4 to the innate immune response to NTHi in the lung. In addition, after we had identified TLR4 as the main receptor contributing to an effective clearance of NTHi, we examined the relative roles of MyD88-dependent and MyD88-independent TLR signaling by making use of MyD88 knockout (KO) and TRIF mutant mice.
Materials and Methods

Animals
Pathogen-free, 8-to 10-wk-old, wild-type (WT) C57BL/6 mice were purchased from Harlan Sprague Dawley. TLR4, MyD88, and TLR2 KO mice, backcrossed six times to a C57BL/6 background, were generated as described previously (21) (22) (23) . CD14 KO mice, backcrossed six times to a C57BL/6 background, were obtained from The Jackson Laboratory. Mice deficient in TRIF were obtained by inducing random germline mutations in C57BL/6 mice using by N-ethyl-N-nitrosourea (13) . Age-and sex-matched animals were used in all experiments. The animal care and use of committee of University of Amsterdam approved all experiments.
Preparation of alveolar macrophages (AM)
AM were harvested from CD14, TLR4, TLR2, and MyD88 KO, TRIF mutant, and WT mice by bronchoalveolar lavage (n ϭ 3-7/strain). The trachea was exposed through a midline incision and cannulated with a sterile 22-gauge Abbocath-T catheter (Abbott Laboratories). Bronchoalveolar lavage was performed by instilling three 0.5-ml aliquots of sterile saline. Total cell numbers were counted from each sample using a hemocytometer. Cells were resuspended in RPMI 1640 containing 1 mM pyruvate, 2 mM L-glutamine, penicillin, streptomycin, and 10% FCS in a final concentration of 1 ϫ 10 4 cells/100 l. Cells were then cultured in 96-well microtiter plates (Greiner) for 2 h and washed with RPMI 1640 to remove nonadherent cells. Adherent monolayer cells were stimulated with LPS (from Escherichia coli O55:B5; 200 ng/ml; Sigma-Aldrich), heat-killed NTHi strain 12 (1 ϫ 10 5 CFU/ml), or RPMI 1640 for 16 h. Supernatants were collected and stored at Ϫ20°C until assayed for TNF and KC.
Experimental infection
H. influenzae strain 12 (donated by S. J. Barenkamp, St. Louis University School of Medicine, St. Louis, MO) is a clinical isolate that has been used by our and other laboratories in investigations on murine pneumonia (24 -26) . The strain was classified as nontypeable based on the absence of agglutination with typing antisera for H. influenzae types a-f (Burroughs Wellcome) and the failure to hybridize with pUO38, a plasmid that contains the entire cap b locus. The NTHi strain was stored at Ϫ80°C in brain heart infusion broth with 20% glycerol. For preparation of the inoculum, bacteria were streaked from frozen aliquots onto a chocolate agar plate and incubated overnight at 37°C in a 5% CO 2 incubator. Next, bacteria obtained from the chocolate agar plate were grown for ϳ3 h to midlogarithmic phase in brain heart infusion broth supplemented with 10 g/ml hemin and 3.5 g/ml NAD at 37°C (all reagents were from Difco). Bacteria were harvested by centrifugation at 1500 ϫ g for 15 min, washed, and resuspended in sterile isotonic saline at a concentration of 1 ϫ 10 7 CFU/50 l, as determined by plating serial 10-fold dilutions on chocolate agar plates. Pneumonia was induced by intranasal (i.n.) inoculation of 50 l (10 7 CFU) of the bacterial suspension as described previously (24) . For this procedure mice were lightly anesthetized by inhalation of isofluorane (Upjohn).
Determination of bacterial outgrowth
Six hours, 24 h, 44 h, and 10 days after infection, mice were anesthetized with Hypnorm (Janssen Pharmaceutica; active ingredients: fentanyl citrate and fluanisone) and midazolam (Roche) and were killed by bleeding from the vena cava inferior. The lungs were harvested and homogenized at 4°C in 4 vol of sterile saline using a tissue homogenizer (BioSpec Products). CFUs were determined from serial dilutions of lung homogenates and blood, plated on chocolate agar plates, and incubated at 37°C at 5% CO 2 for 20 h before colonies were counted.
Preparation of lung tissue for cytokine measurements
For cytokine measurements, lung homogenates were diluted 1/2 in lysis buffer containing 300 mM NaCl, 30 mM Tris, 2 mM MgCl 2 , 2 mM CaCl 2 , FIGURE 1. Membrane CD14, TLR4 and TLR2 are required for responsiveness of AM to NTHi. Freshly isolated AM of WT, CD14, TLR4, and TLR2 KO mice (n ϭ 7/group) were incubated with RPMI 1640 (control) or heat-killed NTHi (equivalent 10 5 CFU; T:E ratio, 1:10) for 16 h before TNF and KC production was measured. ‫,ءءء‬ p Ͻ 0.01; ‫,ءء‬ p Ͻ 0.01 (KO vs WT).
FIGURE 2.
Bacterial clearance: WT (ࡗ, F, and OE) and TLR4, CD14, and TLR2 KO mice (छ, E, and ‚) were infected i.n. with 1 ϫ 10 7 CFU of NTHi. Six, 24, and 44 h as well as 10 days after infection, mice were killed, and bacterial loads were determined in lung homogenates. Data are the mean Ϯ SEM of five to eight mice per group. The p value is derived from curve comparison: ‫,ءء‬ p Ͻ 0.01; ‫,ءءء‬ p Ͻ 0.001 (KO vs WT at the indicated time point).
1% Triton X-100, and pepstatin A, leupeptin and aprotinin (all 20 ng/ml (pH 7.4)) and incubated at 4°C for 30 min. Homogenates were centrifuged at 1500 ϫ g at 4°C for 15 min, and supernatants were stored at Ϫ20°C until assays were performed.
Cytokine and myeloperoxidase (MPO) measurements
For detection of IL-1␣, IL-1␤, IL-6, KC, and MIP-1␣, a Bio-Plex Cytokine Array was used (27) (Bio-Rad; detection limit, 7.8 pg/ml). TNF and MPO were measured using specific ELISAs (for TNF from R&D Systems; for MPO from HyCult Biotechnology). The detection limits were 31.25 pg/ml for TNF and 7.8 pg/ml for MPO.
Histology
Lungs for histology were harvested after infection, fixed in 10% formalin, and embedded in paraffin. Four-micron sections were stained with H&E and analyzed by a pathologist who was blinded for groups. To score lung inflammation and damage, the entire lung surface was analyzed with respect to the following parameters (24, 28, 29) : interstitial inflammation, edema, endothelialitis, bronchitis, and pleuritis. Each parameter was graded on a scale of 0 -4: 0, absent; 1, mild; 2, moderate; 3, severe; and 4, very severe. The total lung inflammation score was expressed as the sum of the scores for each parameter; the maximum was 20.
Statistical analysis
All data are expressed as the mean Ϯ SEM. Serial data were analyzed by one-way ANOVA using GraphPad PRISM version 4.00. When comparing two groups at multiple time points, two-way ANOVA was used. If appropriate, ANOVAs were followed by Bonferroni post test. Statistical analyses of bacterial counts were performed after log transformation. A value of p Ͻ 0.05 was considered statistically significant.
Results
CD14, TLR4, and TLR2 contribute to responsiveness of AM to NTHi in vitro
To gain insight into the requirement of TLR signaling upon the first encounter between bacterium and AM, we tested the capacity of isolated AM to release TNF and KC upon stimulation with LPS (positive control) or heat-killed NTHi (E:T cell ratio, 1:10). As expected, CD14 and TLR4 KO AM failed to respond to LPS, whereas the LPS responsiveness of TLR2 KO AM was indistinguishable from that of WT AM (data not shown). AM from CD14 and TLR4 KO mice also produced significantly less TNF and KC in response to NTHi, whereas WT AM released considerable amounts of TNF and KC (Fig. 1) . In addition, TLR2 KO AM released significantly less TNF and KC upon stimulation with NTHi than WT AM. These data suggest that the responsiveness of AM to NTHi depends on CD14, TLR4, and, to a lesser extent, TLR2.
CD14, TLR4, and TLR2 contribute to pulmonary clearance of NTHi in vivo
Having demonstrated that CD14, TLR4 and TLR2 mediate the responsiveness of AM to NTHi in vitro, we determined whether the lack of these receptors alters host defense after infection with live NTHi in vivo. Therefore, we infected WT, CD14 KO, TLR4 KO, and TLR2 KO mice with NTHi and killed the mice after 6, 24, and 44 h as well as after 10 days. Bacterial counts were similar in the different mouse strains after 6 h of infection (Fig. 2) . Although all strains were able to partially clear the infection during the following days, CD14 and TLR4 KO mice in particular had substantially higher bacterial loads from 24 h onward. By 24 h after infection, bacterial counts were Ͼ600-fold higher in CD14 and TLR4 KO mice compared with WT mice or TLR2 KO mice. Remarkably, 10 days after infection, TLR2 KO mice also displayed higher NTHi loads in their lungs than WT mice. At this time point, bacterial clearance was so efficient in WT mice that only two of seven animals still had detectable bacteria in their lungs (detection limit, 100 CFU/g lung). In contrast, all TLR4 and CD14 KO mice and six of seven TLR2 KO mice had detectable numbers of bacteria in their lungs. Hence, these data suggest that CD14, TLR4, and, to a lesser extent, TLR2 contribute to effective clearance of NTHi from the respiratory tract.
CD14 and TLR4, but not TLR2, are important for early cytokine and chemokine production in the lung after NTHi infection in vivo
The success of combating pulmonary infections strongly depends on the efficacy of the local inflammatory response elicited (30, 31) . To study the extent and kinetics of the inflammatory response, we killed WT, CD14, TLR4, and TLR2 KO mice at multiple time points after infection and measured the concentrations of proinflammatory cytokines (IL-1␣, IL-1␤, TNF, and IL-6) and chemokines (KC and MIP-1␣) in lung homogenates (Fig. 3) . After 6 h of infection, when the bacterial load was still similar in all mouse strains, the pulmonary levels of all inflammatory mediators were strongly reduced, especially in TLR4 and to a lesser extent in CD14 KO mice. Interestingly, from 24 h onward, CD14 KO mice showed much higher levels of IL-1␣, IL-6, and KC in their lungs than WT mice. This response in CD14 KO mice contrasted with the response observed in TLR4 KO mice, in which lung cytokine and chemokine concentrations remained low throughout the entire observation period (with the exception of IL-1␤, which showed a late increase in TLR4 KO mice). In sharp contrast with the altered inflammatory response in lungs of CD14 and TLR4 KO mice, the pulmonary levels of cytokines and chemokines in TLR2 KO mice were largely similar to those in WT mice; only KC levels were modestly reduced in TLR2 KO mice 6 and 48 h after infection.
CD14 and TLR4, but not TLR2, KO mice demonstrate delayed lung inflammation after NTHi infection in vivo
To obtain additional insight into the involvement of CD14, TLR4, and TLR2 in the inflammatory response in the lung upon infection of the airways with NTHi, we semiquantitatively scored lung histology slides generated from WT, CD14, TLR4, and TLR2 KO mice at various time points after infection (Table I and Fig. 4 ). In line with their attenuated initial cytokine/chemokine response, both TLR4 (Fig. 4B ) and CD14 KO (Fig. 4C) mice displayed reduced lung inflammation 6 h after infection compared with WT (Fig. 4A) mice. At later time points, CD14 KO mice in particular (Fig. 4F ) demonstrated more lung inflammation than WT mice (Fig. 4D) . In accordance, lung MPO levels, reflecting the number of neutrophils present in this organ, were lower in CD14 and TLR4 KO mice than in WT mice 6 h after infection, whereas they were higher in these genetically modified animals at 44 h (Table II) . In contrast with the altered lung inflammation in CD14 and TLR4 KO mice, pathology scores (Table I ) and lung MPO levels (Table II) in TLR2 KO mice were not different from those in WT mice, although in line with a reduction in KC levels at 6 h, MPO content was lower in TLR2 KO mice early in infection.
MyD88, but not TRIF, contributes to pulmonary clearance of NTHi in vivo
After having established that a functional CD14/TLR4 complex is important for the initiation of a local inflammatory response and subsequent clearance of NTHi, we were interested in the relative importance of MyD88 and TRIF in host defense against NTHi. At first we studied whether AM from TRIF mutant and MyD88 KO mice were able to respond to NTHi in vitro (Fig. 5) . AM from MyD88 KO failed to respond to NTHi and did not produce significant amounts of TNF and KC. Although AM from TRIF mutant mice produced significantly reduced levels of KC after stimulation with NTHi, no significant difference was detected in TNF production. We then inoculated WT, TLR4 KO, TRIF mutant, and MyD88 KO mice with NTHi and determined pulmonary bacterial loads 44 h after infection, i.e., the time point at which the difference between WT and TLR4 KO mice was most pronounced in our first experiments. Of considerable interest, the lungs of TLR4 and MyD88 KO mice contained much higher NTHi numbers than the lungs of WT mice, differences that were 3-4 logs, on the average (Fig. 6) . In contrast, the bacterial loads harvested from the lungs of TRIF mutant mice were similar to those obtained from WT mice. In line with the studies described above, TLR4 and MyD88 KO, but not TRIF mutant, mice displayed higher cytokine, chemokine, and MPO levels in lung homogenates obtained 44 h after infection compared with WT mice (Table III) . Moreover, semiquantitative inflammation scores were higher in MyD88 KO mice, but the difference for WT mice did not reach statistical significance (Table III and Fig. 7) .
Discussion
NTHi is a commensal Gram-negative bacterium of the human nasopharynx that is able to colonize the epithelium of the upper and lower respiratory tract in patients with underlying lung diseases such as chronic obstructive pulmonary disease, chronic bronchitis, or cystic fibrosis (14 -17) . NTHi is recognized as an important cause of infection of the lower airways and one of the most common causes of community-acquired bacterial pneumonia in adult populations (32, 33) . Therefore, it is of importance to obtain insight into the innate immune response to NTHi respiratory tract infection.
An earlier study by Wang et al. (18) reported that TLR4 mutant C3H/HeJ and C57BL/10ScSn mice were more susceptible to a type b strain of H. influenzae. These TLR4-deficient mice demonstrated reduced pulmonary cytokine and chemokine levels as well as reduced infiltration of neutrophils into the lungs early in infection, which was associated with a delay in clearance of bacteria. We extend these data using a different (nonencapsulated) strain of H. influenzae relevant for human disease and using a genetically "cleaner" mouse model (i.e., TLR4 KO mice backcrossed to a C57BL/6 background). To substantiate and further extend the role a Groups of five to nine mice were i.n. inoculated with 1 ϫ 10 7 CFU of NTHi. After 6, 24, and 44 h as well as 10 days, inflammation was scored on H&E-stained slides (for details, see Materials and Methods). Data are expressed as mean Ϯ SEM. ‫,ء‬ p Ͻ 0.05; ‫,ءء‬ p Ͻ 0.01 vs WT control. a Groups of five to nine mice were i.n. inoculated with 1 ϫ 10 7 CFU of NTHi. After 6 and 44 h, mice were sacrificed, lungs were removed, homogenized and MPO content (g/ml) was measured. Data are expressed as mean Ϯ SEM. ‫,ء‬ p Ͻ 0.05; ‫,ءء‬ p Ͻ 0.01 vs WT control.
of different TLRs during NTHi infection and to elucidate the relative contributions of the MyD88-dependent and MyD88-independent signaling pathways, we included CD14, TLR2, and MyD88 KO as well as TRIF mutant mice in our investigations.
Abundant evidence indicates that TLR4 is the signal-transducing element of the LPS receptor complex (1, 2) . In this complex, CD14 functions as the ligand-binding component that facilitates LPS-induced TLR4 activation. NTHi expresses both LPS and LOS, which, like LPS, has been found to activate cells via TLR4 (34, 35) . In our initial in vitro studies using AM harvested from CD14 and TLR4 KO mice, we established that both components of the LPS receptor complex are indispensable for activation of AM by NTHi. These in vitro data were in part confirmed in the in vivo model of NTHi pneumonia. In particular, TLR4 KO mice displayed a strongly reduced inflammatory response in the lung, especially early after infection, indicating that TLR4 is of crucial importance for mounting an innate immune response to NTHi in the airways. CD14 KO mice also showed less inflammation than WT mice early after infection, albeit to a lesser extent than TLR4 KO mice. A remarkable difference between CD14 KO and TLR4 KO mice became apparent at later time points, when CD14 KO mice demonstrated increased cytokine and chemokine levels in their lungs, whereas in TLR4 KO mice, the pulmonary concentrations of these mediators remained low. It is likely that CD14 KO mice were able to generate an enhanced cytokine response late during the infection via TLR4, TLR2, or other patter recognition receptors due to the higher bacterial load (providing a more potent inflammatory stimulus). The fact that such a late rise in cytokine levels was not observed in TLR4 KO mice suggests that TLR4 is pivotal for this response. In any case, the results obtained in CD14 KO and TLR4 KO mice suggest that the early inflammatory response to NTHi infection is crucial for the subsequent clearance of these bacteria from the respiratory tract; in both mouse strains, NTHi pulmonary loads were several logs higher than in WT mice from 24 h onward.
In vitro studies have identified several TLR2 ligands expressed by NTHi, including lipoproteins D, P2, and P6 (20) . In this study we demonstrate that AM respond to NTHi in part via TLR2, although clearly CD14 and TLR4 play a greater role. It is likely that the response of WT AM is mostly dependent on LPS/LOS present in NTHi, and TLR2 ligands enhance this response. LPS/LOS was able to activate TLR2 KO AM, but without the additional effect of TLR2 ligands, such as lipoprotein D, P2, and P6, TLR2 KO AM responded less well in vitro compared with WT AM. In contrast to our in vitro findings using purified AM, TLR2 KO mice displayed an unaltered inflammatory response to NTHi infection in vivo. A possible explanation for this discrepancy is that in intact animals a variety of factors influence the host response, e.g., natural Abs or complement, which might compensate for the lack of TLR2. In addition, the presence of TLR4 may be able to compensate TLR2 deficiency in vivo, and respiratory epithelial cells also produce proinflammatory mediators that may compensate for a reduced response of AM. Interestingly, 10 days after infection, the lungs of TLR2 KO mice contained ϳ1 log more NTHi than those of WT mice, suggesting that TLR2 deficiency does have a modest impact on bacterial clearance in this model despite the fact that the innate immune response was not impaired to an extent that could be detected by our methods. Additional research is warranted about how FIGURE 5. TRIF and MyD88 are required for responsiveness of AM to NTHi. Freshly isolated AM of WT, TRIF mutant, and MyD88 KO mice (n ϭ 3-6/group) were incubated with RPMI 1640 (control) or heat-killed NTHi (equivalent 10 5 CFU; T:E ratio, 1:10) for 16 h before TNF and KC production was measured. ‫,ءء‬ p Ͻ 0.01 vs WT. TLR2 influences the late clearance of NTHi from the airways after intranasal infection. TLR4 triggers at least two intracellular signaling pathways, one mediated by the common TLR adaptor MyD88 and one that relies on TRIF. The different intracellular adaptors of TLR4 lead to different ways of cell activation; MyD88 activation leads to early phase NF-B activation using, among others, IL-1R-associated kinase and TNFR-associated factor-6 (1), whereas activation of TRIF also leads to NF-B activation, but with delayed kinetics (11) . The MyD88-independent pathway activates IFN regulatory factor, resulting in the expression of IFN-␤ (11, 36) . Considering that TLR4 especially appeared to be of importance for the clearance of NTHi from the lungs in our first experiments, we determined the relative contributions of MyD88 and TRIF in antibacterial defense in this model. First, we demonstrated that AM from MyD88 KO mice failed to respond to NTHi during 16 h of stimulation. This finding points out that the MyD88-dependent pathway is crucial in the in vitro response to NTHi. Interestingly, TRIF mutant AM produced less KC than WT AM in response to NTHi despite a functional MyD88-dependent signaling pathway. These data suggest that TRIF contributes to the response of AM to NTHi in vitro. Knowledge of the relative roles of the MyD88-dependent and MyD88-independent pathways of TLR4 signaling in host defense against pulmonary pathogens in vivo is highly limited. Two recent studies investigated the role of MyD88 in Pseudomonas aeruginosa pneumonia (37, 38) . Both studies focused on the early host response (up to 24 h), showing that in the absence of MyD88, the clearance of Pseudomonas is impaired. In the present study we evaluated the roles of MyD88 and TRIF in the clearance of NTHi by determining the bacterial load 44 h after infection, which is the time point at which our first studies had established an important role for TLR4. Interestingly, TRIF mutant mice were indistinguishable from WT mice with respect to bacterial load and lung inflammation. In contrast, MyD88 KO mice demonstrated an NTHi load in their lungs that was Ͼ4 logs higher than that measured in WT lungs, which was associated with more pronounced pulmonary inflammation. In this regard, MyD88 KO mice resembled TLR4 KO mice. Because MyD88 also serves as the essential adaptor for other IL-1R/TLR family members, including the type I IL-1R and IL-18R, and all TLRs except for TLR3, it is intriguing to document that even MyD88 KO mice are apparently able to mount an inflammatory response in the lung in the presence of a very high bacterial burden. It will be of interest to study which part of the immune system is responsible for the increased inflammation in the MyD88 KO mice. Possible MyD88-independent mediators include complement and Ab responses and the TRIF pathway of TLR4 signaling.
Our study demonstrates that TLR4 is of utmost importance for a successful host defense in pulmonary infection with NTHi, and that for an effective function of TLR4, CD14 (in the extracellular compartment) and MyD88 (intracellular) are crucial. Finally, our study reveals that the role of the MyD88-independent, TRIF-dependent pathway of TLR4 signaling is of minor importance for the clearance of NTHi from the respiratory tract.
